We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Monday
May 18
10:30 - 11:30
Viktoria
Lower GI tract cancers
Joanna Socha, Poland;
Karol Paciorek, Poland
Proffered Papers
Clinical
10:30 - 11:30
Immunotherapy based total neoadjuvant therapy with or without short-course radiotherapy for locally advanced rectal cancer (TORCH-iTNT NCT06281405)
Fan Xia, China
-2846
10:30 - 11:30
Early regression index-guided dose escalation in locally advanced rectal cancer: long term results of the prospective THUNDER-2 trial (NCT04815694)
Giuditta Chiloiro, Italy
-3240
10:30 - 11:30
Quality control and the influence of radiotherapy on locoregional recurrences in the RAPIDO trial
Max Tanaka, The Netherlands
-1144
10:30 - 11:30
The ReRad III trial: One-year efficacy, adverse events and feasibility of reirradiation for recurrent Anal Cancer (NCT05055635).
Camilla Kronborg, Denmark
-2211
10:30 - 11:30
Introducing the EORTC QLQ-ANL27, a validated anal cancer-specific health-related quality of life questionnaire
Vasilis Vasiliou, Cyprus
-2449
10:30 - 11:30
Neoadjuvant radiotherapy combined with CAPOX and PD-1 inhibitor for MSS/pMMR high-risk locally advanced colon cancer: a randomized phase ? Trial
Hui Zhang, China
-3063